Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction.
about
Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseasesThe effect of adrenomedullin on the L-type calcium current in myocytes from septic shock rats: signaling pathwayEarly course of microcirculatory perfusion in eye and digestive tract during hypodynamic sepsis.Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemia.Timing of vasopressor initiation and mortality in septic shock: a cohort studyEffects of selective β1-adrenoceptor blockade on cardiovascular and renal function and circulating cytokines in ovine hyperdynamic sepsisThe soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systemsAcute actions and novel targets of matrix metalloproteinases in the heart and vasculatureAn essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.Diastolic dysfunction and mortality in early severe sepsis and septic shock: a prospective, observational echocardiography study.Platelet-derived exosomes from septic shock patients induce myocardial dysfunction.Endothelial NOS (NOS3) impairs myocardial function in developing sepsis.Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression.Bedside echocardiography is useful in assessing children with fluid and inotrope resistant septic shocksGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.The heart and the gut.PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis.Complement and sepsis-induced heart dysfunction.Early norepinephrine decreases fluid and ventilatory requirements in pediatric vasodilatory septic shock.Adiponectin ameliorates endotoxin-induced acute cardiac injury.The effects of tumor necrosis factor-alpha on systolic and diastolic function in rat ventricular myocytes.Dual Behavior of Exosomes in Septic Cardiomyopathy.
P2860
Q21296645-EA52132C-E5C9-49A7-B7CB-3B7C09F87DDCQ28569073-571DDAEF-C3DA-47AA-BD46-BBE021996545Q30536441-78E3E137-694B-4EB4-A9DF-1792D5EE3637Q33511198-6E4C51D1-EB48-46D3-B8ED-4FE8C7AEB459Q33822349-D0A19C44-B896-4EAC-9DF8-7E4979CC9D3AQ34670866-73403921-1586-48BF-9C84-8A58C6C9A28DQ34981386-65851FDF-CD4D-441F-A817-91A94D0C0950Q35995215-0BC858D2-64D7-4DA0-AAD1-E3752A827A3CQ36227873-ED0942CB-E03E-43BA-B3BC-0A5DAE577845Q36440645-278AF513-F45E-45D9-A4EC-B4BB514B3916Q36465390-E46175E6-7F9D-4715-B325-7D5742BA6D4CQ36683881-DD5713D7-250B-436F-8A23-584FDF63DA9CQ36955252-B13550BD-8162-4FFF-8E41-0D3D5C025EDAQ37230368-3B9BCAFF-0A00-44B2-970E-E748742AC952Q37298332-42189013-F3F9-44B1-AC1B-C8A884569183Q38122310-CC7C8EFA-476A-49FD-A8B7-6393C3527989Q39158049-640CBD34-A3B5-4590-90CC-E87AC7B5ECDDQ40417787-A4AA7157-16AD-4A7B-8796-50BB070D1491Q41527504-0200E4F3-CEEE-428D-BB3C-87AB8D039FF1Q41986321-ED45FC0F-1B17-4822-BF73-7FD0DB96DE5EQ42881346-E73918C6-D755-45BC-A360-EAB533279D92Q49942889-226E9233-64DE-446B-B716-012B51430D42
P2860
Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Myocardial dysfunction in sept ...... of cardiovascular dysfunction.
@ast
Myocardial dysfunction in sept ...... of cardiovascular dysfunction.
@en
Myocardial dysfunction in sept ...... of cardiovascular dysfunction.
@nl
type
label
Myocardial dysfunction in sept ...... of cardiovascular dysfunction.
@ast
Myocardial dysfunction in sept ...... of cardiovascular dysfunction.
@en
Myocardial dysfunction in sept ...... of cardiovascular dysfunction.
@nl
prefLabel
Myocardial dysfunction in sept ...... of cardiovascular dysfunction.
@ast
Myocardial dysfunction in sept ...... of cardiovascular dysfunction.
@en
Myocardial dysfunction in sept ...... of cardiovascular dysfunction.
@nl
P2093
P356
P1476
Myocardial dysfunction in sept ...... of cardiovascular dysfunction.
@en
P2093
P304
P356
10.1053/JCAN.2001.22317
P577
2001-06-01T00:00:00Z